Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD

Clinical trial NCT02515669 · TERMINATED

Trial details

NCT number: NCT02515669
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Muscular Dystrophy (DMD)

Start date: 2015-12-02
Primary completion: 2018-02-08
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.